Gilead Sciences News - GILD

Best deals to access real time data!
Big Cap Pro Monthly Subscription for only ~~$52.04~~
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB Monthly Subscription for only ~~$67.09~~
Level 1 Starter Monthly Subscription for only ~~$15.87~~
VAT not included

Company Name	Stock Ticker Symbol	Market	Type
Gilead Sciences Inc	GILD	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	High Price	Low Price	Open Price	Close Price	Last Traded
	0.79	1.22%	65.30	65.74	64.61	64.83	64.51	16:00:44

more quote information »

Recent News

Date	Time	Source	Heading
10/15/2019	4:02	IHNW	FeaturedVersus Systems Powers Rewards for League of Legends on OMEN
10/15/2019	6:00	IHNW	Featured Global Consortium, Inc., Opens Phase One of the Cannabis Mall
10/15/2019	09:11	DJN	Gilead Sciences Names Andrew Dickinson Chief Financial..
10/15/2019	09:04	EDGAR	Current Report Filing (8-k)
10/15/2019	08:30	BW	Gilead Sciences Appoints Andrew Dickinson as Chief Financial..
10/10/2019	19:10	DJN	Gilead Sciences, Galapagos See Efficacy in Advanced..
10/10/2019	18:00	BW	Gilead & Galapagos Announce Efficacy & Safety Results of..
10/10/2019	16:05	BW	Gilead Sciences to Release Third Quarter 2019 Financial..
10/08/2019	02:00	BW	Gilead Sciences Submits New Drug Application for Filgotinib..
10/07/2019	09:23	DJN	Gilead Sciences Names Merdad Parsey Chief Medical Officer
10/07/2019	08:30	BW	Gilead Sciences Appoints Merdad Parsey, MD, PhD as Chief..
10/04/2019	08:30	BW	Gilead Presents New Data From the Company’s HIV Clinical..
10/03/2019	15:34	DJN	Gilead Says FDA Approves Descovy for HIV Pre-Exposure..
10/03/2019	14:49	BW	U.S. Food and Drug Administration Approves Descovy® for HIV..
9/16/2019	03:02	DJN	A Plan to Fight Hep C -- WSJ
9/13/2019	10:20	DJN	Louisiana's Deal for Hepatitis C Drugs May Serve as Model --..
9/13/2019	00:36	DJN	Louisiana's Deal for Hepatitis C Drugs May Serve as Model --..
9/09/2019	07:30	BW	Gilead Sciences & the Elton John AIDS Foundation Launch..
9/04/2019	08:45	NNW	Gene Therapy Treatments Offer Hope for Cancer Patients
8/29/2019	16:43	EDGAR	Statement of Changes in Beneficial Ownership (4)
8/27/2019	16:28	EDGAR	Current Report Filing (8-k)
8/26/2019	16:34	BW	Gilead Sciences to Present at the Morgan Stanley Global..
8/26/2019	11:54	PRNCA	Alberta Provides Access to Biktarvy® for the Treatment of..
8/23/2019	16:01	BW	Gilead and Galapagos Complete Closing of Their..
8/20/2019	15:13	EDGAR	Statement of Changes in Beneficial Ownership (4)
8/15/2019	17:23	DJN	European Medicines Agency Reviews Arthritis Treatment by..
8/15/2019	16:01	BW	European Medicines Agency Validates Marketing Application..
8/15/2019	08:00	PRNCA	Québec Provides Access to Biktarvy® for the Treatment of HIV
8/13/2019	18:48	EDGAR	Statement of Changes in Beneficial Ownership (4)
8/09/2019	08:30	BW	China National Medical Products Administration Approves..
8/08/2019	09:23	DJN	Agenus: FDA Accepts AGEN2373 IND, Triggering $7.5 Million..
8/07/2019	21:38	DJN	Medicare Moves to Cover Costly Cell Therapies
8/07/2019	20:44	BW	Gilead Sciences Statement on U.S. Food and Drug..
8/07/2019	12:44	DJN	Assembly Biosciences Shares Rise as Gilead Vet Takes Helm
8/06/2019	16:28	EDGAR	Quarterly Report (10-q)
8/06/2019	08:00	BW	Ontario Provides Access to Biktarvy® for the Treatment of..
7/30/2019	18:00	DJN	Gilead Sciences Revises Some of Its 2019 Guidance
7/30/2019	16:53	DJN	Gilead Sciences Posts Higher 2Q Earnings, Sales
7/30/2019	16:08	EDGAR	Current Report Filing (8-k)
7/30/2019	16:02	BW	Gilead Sciences Announces Third Quarter 2019 Dividend
7/30/2019	16:01	BW	Gilead Sciences Announces Second Quarter 2019 Financial..
7/26/2019	17:41	EDGAR	Statement of Changes in Beneficial Ownership (4)
7/25/2019	18:38	EDGAR	Statement of Changes in Beneficial Ownership (4)
7/23/2019	17:25	DJN	Gilead Releases Data From HIV Cure Research Program on..
7/23/2019	16:00	BW	Gilead Announces Latest Data in Ongoing HIV Cure Research..
7/23/2019	11:00	BW	Gilead Presents New Findings on Profile of Descovy® for..
7/22/2019	12:00	BW	Gilead Presents New Data on Biktarvy® for the Treatment of..
7/22/2019	11:51	DJN	Gilead Sciences Says Study of GS-6207 Showed HIV Capsid..
7/22/2019	11:00	BW	Gilead Presents Proof-of-Concept Data for GS-6207, a..
7/22/2019	09:08	DJN	Gilead Licenses Durect's Saber Technology for Injectable HIV..
7/19/2019	09:19	DJN	Gilead Licenses Respiratory, Herpes Antiviral Research..
7/19/2019	08:30	BW	Gilead Sciences Licenses Respiratory and Herpes Antiviral..

See more news about this stock »

Gilead Sciences News - GILD

Recent News

GILD Historical - 1 Day

GILD Historical - 1 Year